T0449 |
Menadione
|
58-27-5
|
98%
|
|
Menadione is a synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after ...
|
T2368L |
Edoxaban
|
480449-70-5
|
98%
|
|
Edoxaban (DU-176) is a selective, potent and orally active factor Xa (FXa) inhibitor with K i s of 0.561 nM and 2.98 nM for free FXa and prothrombinase, respecti...
|
T41031 |
Protamine sulfate
|
9009-65-8
|
98%
|
|
Protamine sulfate is a polycationic peptide that serves as an antiheparin agent. This compound can neutralize the anticoagulant action of heparin and enhance lip...
|
T22246 |
Argatroban Monohydrate
|
141396-28-3
|
98%
|
|
Argatroban Monohydrate is a specific thrombin inhibitor, which is a non-heparin anticoagulant, prevents the formation of thrombi.
|
T1184 |
Rivaroxaban
|
366789-02-8
|
98%
|
|
Rivaroxaban is an orally bioavailable oxazolidinone derivative and direct inhibitor of the coagulation factor Xa with anticoagulant activity. Upon oral administr...
|
T2562 |
Eltrombopag
|
496775-61-2
|
98%
|
|
Eltrombopag, an orally active thrombopoietin receptor agonist with megakaryopoiesis stimulating activity, binds to and stimulates the platelet thrombopoietin rec...
|
T6370 |
AEBSF hydrochloride
|
30827-99-7
|
98%
|
|
AEBSF hydrochloride is an irreversible inhibitor of serine proteases, such as chymotrypsin, kallikrein, thrombin, plasmin, and trypsin.
|
T2368 |
Edoxaban Tosylate Monohydrate
|
1229194-11-9
|
98%
|
|
Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention.
|
T7417 |
Avatrombopag
|
570406-98-3
|
98%
|
|
Avatrombopag is a new oral thrombopoietin (TPO) receptor agonist, activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platele...
|
T6531 |
Heparin sodium salt
|
9041-08-1
|
98%
|
|
Heparin sodium is a sulfated polysaccharide, which belongs to the family of glycosaminoglycans. It is utilized as an anticoagulant and interacted with diverse p...
|
T22323 |
Enoxaparin sodium
|
679809-58-6
|
98%
|
|
Enoxaparin sodium is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment my...
|
T6236 |
Ozagrel
|
82571-53-7
|
98%
|
|
Ozagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet, used for the improvement of postoperative cerebrova...
|
T0448 |
(S)-(+)-Ibuprofen
|
51146-56-6
|
98%
|
|
Dexibuprofen, S(+)-ibuprofen, is a non-steroidal anti-inflammatory drug (NSAID), inhibiting cyclooxygenase (COX).
|
T5519 |
Bivalirudin
|
128270-60-0
|
98%
|
|
Bivalirudin is a reversible inhibitor of α- and ζ-thrombin (Kis = 2.56 and 1.84 nM, respectively), enzymes that exhibit high fibrinogen-clotting activities.
|
T17265 |
Ximelagatran
|
192939-46-1
|
98%
|
|
Ximelagatran, a direct thrombin inhibitor, can be taken orally and acts solely by inhibiting the actions of thrombin. Ximelagatran is converted to the active age...
|
T6295 |
Dabigatran
|
211914-51-1
|
98%
|
|
Dabigatran is a THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the ri...
|
T10951 |
Dabigatran ethyl ester hydrochloride
|
211914-50-0
|
98%
|
|
Dabigatran ethyl ester hydrochloride is an effective inhibitor of ribosyl dihydronicotinic acid amide dehydrogenase (NQO2) with an IC50 value of 0.8 μM and is a ...
|
T0389 |
Dabigatran etexilate
|
211915-06-9
|
98%
|
|
Dabigatran is a thrombin inhibitor, which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation.
|
T0438 |
Proflavine Hemisulfate
|
1811-28-5
|
98%
|
|
Proflavine Hemisulfate is the hemisulfate salt form of proflavine, an acridine-derived fluorescent contrast and disinfectant agent that can potentially be used f...
|
T7053 |
P-Hydroxycinnamic acid
|
7400-08-0
|
98%
|
|
p-Hydroxycinnamic acid can inhibit platelet activity, with IC50s of 371 μM, 126 μM for thromboxane B2 production and lipopolysaccharide-induced prostaglandin E2 ...
|